Mark C. Lavigne

1.5k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Mark C. Lavigne is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark C. Lavigne has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark C. Lavigne's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Estrogen and related hormone effects (4 papers) and Coronary Interventions and Diagnostics (3 papers). Mark C. Lavigne is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Estrogen and related hormone effects (4 papers) and Coronary Interventions and Diagnostics (3 papers). Mark C. Lavigne collaborates with scholars based in United States, France and Canada. Mark C. Lavigne's co-authors include Peter W. Ramwell, Michel Y. Farhat, Thomas L. Leto, Michael J. Eppihimer, Harry L. Malech, Steven M. Holland, Ji‐Liang Gao, Philip M. Murphy, Jiming Wang and You‐Hong Cui and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.

In The Last Decade

Mark C. Lavigne

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The vascular protective effects of estrogen

1996 529 citations Michel Y. Farhat, Mark C. Lavigne et al. The FASEB Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark C. Lavigne United States	14	371	326	324	283	257	22	1.2k
Antonella Antonelli Italy	10	561 1.5×	147 0.5×	249 0.8×	204 0.7×	413 1.6×	12	1.6k
Fernando Delgado‐López Chile	13	579 1.6×	458 1.4×	119 0.4×	167 0.6×	239 0.9×	21	1.4k
Michael J. Kraakman Australia	17	456 1.2×	419 1.3×	119 0.4×	202 0.7×	413 1.6×	29	1.5k
MyTrang Nguyen United States	19	742 2.0×	316 1.0×	195 0.6×	84 0.3×	449 1.7×	27	2.0k
Tarja Kunnas Finland	22	303 0.8×	137 0.4×	312 1.0×	256 0.9×	126 0.5×	68	1.2k
Krishna Reddy United States	26	609 1.6×	263 0.8×	75 0.2×	84 0.3×	246 1.0×	39	1.6k
Yanhong Wu China	26	604 1.6×	137 0.4×	323 1.0×	99 0.3×	159 0.6×	73	1.6k
Francesca Mercuri Australia	16	329 0.9×	215 0.7×	87 0.3×	305 1.1×	130 0.5×	25	1.1k
Helen Imrie United Kingdom	22	376 1.0×	367 1.1×	446 1.4×	551 1.9×	307 1.2×	39	1.6k
Kazushige Adachi Japan	14	567 1.5×	191 0.6×	299 0.9×	223 0.8×	131 0.5×	33	1.3k

Countries citing papers authored by Mark C. Lavigne

Since Specialization

Citations

This map shows the geographic impact of Mark C. Lavigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Lavigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Lavigne more than expected).

Fields of papers citing papers by Mark C. Lavigne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Lavigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Lavigne. The network helps show where Mark C. Lavigne may publish in the future.

Co-authorship network of co-authors of Mark C. Lavigne

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Lavigne. A scholar is included among the top collaborators of Mark C. Lavigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Lavigne. Mark C. Lavigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lavigne, Mark C., et al.. (2020). Hand hygiene feedback impacts compliance. American Journal of Infection Control. 49(7). 907–911. 14 indexed citations

Lavigne, Mark C.. (2016). Nonbronchoscopic Methods [Nonbronchoscopic Bronchoalveolar Lavage (BAL), Mini-BAL, Blinded Bronchial Sampling, Blinded Protected Specimen Brush] to Investigate for Pulmonary Infections, Inflammation, and Cellular and Molecular Markers: A Narrative Review. Clinical Pulmonary Medicine. 24(1). 13–25. 6 indexed citations

Lavigne, Mark C., et al.. (2011). Antirestenotic Mechanisms of Everolimus on Human Coronary Artery Smooth Muscle Cells. Journal of Cardiovascular Pharmacology. 59(2). 165–174. 21 indexed citations

Lavigne, Mark C., et al.. (2010). Anti-Proliferative Compounds for the Prevention of Restenosis: Anti-Restenotic Mechanisms of Paclitaxel Action. Current Pharmaceutical Design. 16(36). 3989–4001. 5 indexed citations

Leto, Thomas L., Mark C. Lavigne, Kristen Lekstrom, et al.. (2007). The K-562 Cell Model for Analysis of Neutrophil NADPH Oxidase Function. Methods in molecular biology. 412. 365–383. 8 indexed citations

Lavigne, Mark C. & Michael J. Eppihimer. (2005). Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochemical and Biophysical Research Communications. 330(1). 194–203. 58 indexed citations

Eppihimer, Michael J., et al.. (2004). Relative Contributions of α₄ and α_L Integrins to IL‐4‐Induced Leukocyte Rolling and Adhesion. Microcirculation. 11(8). 655–668. 3 indexed citations

Lavigne, Mark C., Paresh Thakker, Jason R. Gunn, et al.. (2004). Human bronchial epithelial cells express and secrete MMP-12. Biochemical and Biophysical Research Communications. 324(2). 534–546. 53 indexed citations

Lavigne, Mark C., Philip M. Murphy, Thomas L. Leto, & Ji‐Liang Gao. (2002). The N-formylpeptide receptor (FPR) and a second Gi-coupled receptor mediate fMet–Leu–Phe-stimulated activation of NADPH oxidase in murine neutrophils. Cellular Immunology. 218(1-2). 7–12. 20 indexed citations

10.

Gao, Ji‐Liang, et al.. (2001). The Endogenous Opioid Spinorphin Blocks fMet-Leu-Phe-Induced Neutrophil Chemotaxis by Acting as a Specific Antagonist at the N -Formylpeptide Receptor Subtype FPR. The Journal of Immunology. 167(11). 6609–6614. 30 indexed citations

11.

Tiffany, H. Lee, Mark C. Lavigne, You‐Hong Cui, et al.. (2001). Amyloid-β Induces Chemotaxis and Oxidant Stress by Acting at Formylpeptide Receptor 2, a G Protein-coupled Receptor Expressed in Phagocytes and Brain. Journal of Biological Chemistry. 276(26). 23645–23652. 143 indexed citations

12.

Lavigne, Mark C., Harry L. Malech, Steven M. Holland, & Thomas L. Leto. (2000). Genetic requirement of p47 phox for superoxide production by murine microglia. The FASEB Journal. 15(2). 285–287. 50 indexed citations

13.

Lavigne, Mark C., Peter W. Ramwell, & Robert Clarke. (1999). Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation. Steroids. 64(7). 472–480. 9 indexed citations

14.

Lavigne, Mark C., Peter W. Ramwell, & Robert Clarke. (1999). Growth and phenotypic characterization of porcine coronary artery smooth muscle cells. In Vitro Cellular & Developmental Biology - Animal. 35(3). 136–143. 6 indexed citations

15.

Lavigne, Mark C., et al.. (1998). Stereoisomer-Specific Inhibition of Superoxide Anion-Induced Rat Aortic Smooth-Muscle Cell Proliferation by 17β-Estradiol is Estrogen Receptor Dependent. Journal of Cardiovascular Pharmacology. 31(4). 499–505. 16 indexed citations

16.

Mills, Edward, Kazuyo Takeda, Zu-Xi Yu, et al.. (1998). Nerve Growth Factor Treatment Prevents the Increase in Superoxide Produced by Epidermal Growth Factor in PC12 Cells. Journal of Biological Chemistry. 273(35). 22165–22168. 63 indexed citations

17.

Lavigne, Mark C., et al.. (1996). Specific binding of estradiol to rat coronary artery smooth muscle cells. The Journal of Steroid Biochemistry and Molecular Biology. 58(1). 83–88. 17 indexed citations

18.

Farhat, Michel Y., Mark C. Lavigne, & Peter W. Ramwell. (1996). The vascular protective effects of estrogen. The FASEB Journal. 10(5). 615–624. 529 indexed citations breakdown →

19.

Farhat, Michel Y., et al.. (1995). Protection by Estradiol 17β Against the Development of Hypoxic Pulmonary Hypertension in Male Rats. Endothelium. 3(3). 201–207. 1 indexed citations

20.

Jabara, Haifa H., Steven J. Ackerman, Donata Vercelli, et al.. (1988). Induction of interleukin-4-dependent IgE synthesis and interleukin-5-dependent eosinophil differentiation by supernatants of a human helper T-cell clone. Journal of Clinical Immunology. 8(6). 437–446. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact